Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Ribavirin
Page 1 of 2 ( 52 items )
<<
1
2
>>
1
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
2/24/2023 1:35:50 PM |
Browse: 718 |
Download: 1624
2
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM |
Browse: 774 |
Download: 2297
3
Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages
6/24/2021 7:26:32 AM |
Browse: 770 |
Download: 2327
4
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM |
Browse: 1010 |
Download: 2933
5
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
5/6/2019 10:43:10 AM |
Browse: 1472 |
Download: 2900
6
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM |
Browse: 1557 |
Download: 3178
7
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM |
Browse: 1573 |
Download: 2901
8
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM |
Browse: 1813 |
Download: 3398
9
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM |
Browse: 1463 |
Download: 3075
10
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
1/22/2017 8:28:00 AM |
Browse: 1918 |
Download: 3173
11
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM |
Browse: 1418 |
Download: 3183
12
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM |
Browse: 2047 |
Download: 3551
13
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM |
Browse: 1791 |
Download: 2283
14
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM |
Browse: 2108 |
Download: 3553
15
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
3/2/2016 1:35:00 PM |
Browse: 2160 |
Download: 4106
16
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
2/25/2016 7:04:00 PM |
Browse: 1501 |
Download: 2924
17
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM |
Browse: 1749 |
Download: 3452
18
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy
1/23/2016 5:08:00 PM |
Browse: 1786 |
Download: 2592
19
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
1/20/2016 5:04:00 PM |
Browse: 1531 |
Download: 2518
20
Ribavirin: Past, present and future
1/15/2016 9:49:00 AM |
Browse: 1683 |
Download: 2415
21
Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
1/15/2016 9:49:00 AM |
Browse: 1705 |
Download: 2170
22
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM |
Browse: 2494 |
Download: 3216
23
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM |
Browse: 2213 |
Download: 2516
24
Hepatitis C in hemodialysis patients
12/2/2015 12:01:00 PM |
Browse: 1818 |
Download: 2172
25
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
11/27/2015 5:17:00 PM |
Browse: 1757 |
Download: 3369
26
Hepatitis E virus infection: Epidemiology and treatment implications
11/12/2015 5:09:00 PM |
Browse: 1589 |
Download: 2914
27
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
11/9/2015 6:35:00 PM |
Browse: 1702 |
Download: 2339
28
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM |
Browse: 1686 |
Download: 3178
29
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM |
Browse: 1575 |
Download: 3000
30
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
5/19/2015 5:28:00 PM |
Browse: 1721 |
Download: 2413
31
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
5/18/2015 5:02:00 PM |
Browse: 1863 |
Download: 2216
32
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
5/18/2015 5:02:00 PM |
Browse: 1508 |
Download: 2498
33
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM |
Browse: 1844 |
Download: 2879
34
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM |
Browse: 1828 |
Download: 2499
35
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM |
Browse: 1940 |
Download: 2679
36
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM |
Browse: 1619 |
Download: 2062
37
Study of pruritus in chronic hepatitis C patients
12/20/2014 9:24:00 PM |
Browse: 1514 |
Download: 2452
38
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM |
Browse: 1631 |
Download: 2331
39
New treatments for chronic hepatitis C: an overview for paediatricians
12/5/2014 11:43:00 AM |
Browse: 1862 |
Download: 2809
40
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM |
Browse: 1826 |
Download: 2209
41
Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients
9/16/2014 4:56:00 PM |
Browse: 1594 |
Download: 1409
42
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
9/16/2014 3:23:00 PM |
Browse: 1474 |
Download: 1284
43
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
9/15/2014 8:53:00 PM |
Browse: 1619 |
Download: 1760
44
Hepatitis C, stigma and cure
9/12/2014 8:41:00 PM |
Browse: 1792 |
Download: 1726
45
Hepatitis C genotype 6: A concise review and response-guided therapy proposal
9/10/2014 4:40:00 PM |
Browse: 1603 |
Download: 1730
46
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
9/5/2014 2:19:00 PM |
Browse: 1406 |
Download: 1693
47
Challenges in managing hepatitis C virus infection in cancer patients
9/1/2014 2:51:00 PM |
Browse: 1421 |
Download: 1437
48
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM |
Browse: 1618 |
Download: 2012
49
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
8/28/2014 5:50:00 PM |
Browse: 1881 |
Download: 1905
50
Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
8/26/2014 3:10:00 PM |
Browse: 1574 |
Download: 2316
Page 1 of 2 ( 52 items )
<<
1
2
>>
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.